Clinical Trial Update: SAM-e for the Treatment of Depression in Patients With Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting completed Phase 2 and Phase 3 results for SAM-e in treating depression in patients with Parkinson's disease; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Parkinson Disease

Drugs mentioned

• SAM-e (S-adenosyl-L-methionine)

Snippet

Sponsor: NYU Langone Health | Conditions: Parkinson's Disease, Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-07-13